Table of Contents
At Stanford’s brain stimulation laboratory, psychiatrist Dr. Nolan Williams has spent years studying two seemingly different tools, psychedelics and neurostimulation, and has come to see them as working toward a shared destination: a more flexible, more responsive brain. In a recent conversation, Williams laid out the case that both approaches may promote neuroplasticity, the brain’s capacity to reorganize itself, and that this shared mechanism could explain their therapeutic promise for mood disorders.
Two Tools, One Direction Toward Brain Rewiring
Neurostimulation techniques, such as transcranial magnetic stimulation and deep brain stimulation, work by delivering targeted electrical or magnetic pulses to specific brain regions. Psychedelics, including psilocybin, work through a very different route, binding to serotonin receptors and triggering a cascade of signaling activity. Yet Williams suggests both may ultimately promote the same biological condition: a loosening of rigid neural patterns that can trap people in cycles of depression, anxiety, or other mood disorders.
This idea of the brain becoming more malleable, more open to forming new connections, is sometimes described in research settings as a period of heightened plasticity. Williams frames both tools as ways of creating or extending that window, giving the brain an opportunity to learn its way out of entrenched suffering.
Clinical Applications for Mood Disorders and Treatment-Resistant Conditions
Williams’s work is situated in the context of treatment-resistant conditions, patients who have not responded adequately to conventional medication or therapy. Both psychedelic-assisted treatment and advanced neurostimulation protocols are being studied in this population, where the need for new approaches is most acute.
The overlap Williams identifies raises an important clinical question: if both tools promote neuroplasticity, might they work even more effectively in combination, or in careful sequence? That remains an open hypothesis. No clinical trial results comparing or combining the two approaches are cited in the source material, and any such application would require rigorous study before conclusions could be drawn.
What Does Neuroplasticity Mean for Psychedelic-Assisted Treatment?
Neuroplasticity, in this context, refers to the brain’s capacity to reorganize its own patterns, forming new connections where old, rigid ones once dominated. Williams’s hypothesis is that both psilocybin and neurostimulation may open a window of heightened plasticity, during which the brain becomes more responsive to change. For patients with mood disorders, that window may represent a meaningful opportunity for therapeutic progress that conventional treatments have not provided.
How Does Psilocybin Compare to Neurostimulation for Depression?
According to Williams, psilocybin and neurostimulation techniques such as transcranial magnetic stimulation and deep brain stimulation approach the same underlying goal, promoting a more flexible brain state, through entirely different mechanisms. Psilocybin binds to serotonin receptors, while neurostimulation delivers electrical or magnetic pulses to targeted brain regions. Whether one approach outperforms the other for depression, or whether combining them offers added benefit, remains an active area of inquiry without established clinical consensus.
What the Science Is, and Is Not, Saying
It is worth holding this conversation clearly. Williams is a respected researcher, but the source here is a public discussion, not a peer-reviewed publication. The framing that psychedelics and neurostimulation share neuroplasticity mechanisms is a working hypothesis with growing supporting evidence, not an established consensus. The science is promising and serious, and it deserves to be treated as exactly what it is: an active, evolving inquiry into how the brain changes, and how that change might relieve suffering.
For those drawn to psilocybin not as a clinical intervention but as a sacramental practice, Williams’s framework still offers something worth sitting with. The idea that the brain can rewire itself, that patterns long assumed to be fixed are in fact capable of movement, is both a scientific observation and, for many, a deeply felt truth.
The Softening the Science Points Toward
What strikes us in Williams's framing is the word plasticity itself. To be plastic is to be capable of being shaped, to be neither rigid nor formless but responsive. That quality, the willingness to be changed by experience, is at the heart of what many in our community seek when they approach the sacrament with intention.
Science is now finding language for something practitioners have long described in other words: the opening, the dissolution of fixed narratives, the sense that a way of being that seemed permanent is suddenly revealed as one option among many. Williams's work does not explain the mystery, but it sits respectfully at its edge.
We hold this research with gratitude and with care. It is not a prescription or a protocol. It is a lamp being carried into a large, largely unmapped room.
If this conversation stirs something in you, whether curiosity about the neuroscience or a deeper question about your own patterns and their possibility for change, we welcome you to explore further through our Awakening resources on the Golden Path. The science and the inner journey are not in competition. They are, as Williams seems to sense, pointing at the same quiet fact.
May love guide the hearts of all beings.
